Literature DB >> 24144030

Screening of differentially expressed microRNA in ulcerative colitis related colorectal cancer.

Yong-Gang Tan1, Yong-Feng Zhang, Chang-Jun Guo, Min Yang, Man-Yin Chen.   

Abstract

OBJECTIVE: To investigate the differential expression of microRNA (miRNA) in colon between ulcerative colitis (UC) and ulcerative colitis related colorectal cancer (UCRCC).
METHODS: An UC mouse model was built by dextran sodium sulfate, and an UCRCC mouse model by dextran sodium sulfate and 1,2-diformylhydrazine. RNAs were extracted from the colon, purified and hybridized with fluorescence-labeled miRNA oligonucleotide gene chip. Real-time fluorescence quantitative PCR was used to verify the expression variation of miRNA. SAM was employed for the data analysis.
RESULTS: The up-regulated miRNAs in colon cancer included has-miR-194, has-miR-215, has-miR-93, has-miR-192, has-miR-92a, has-miR-29b, and has-miR-20a (median false discovery rate<5%), while the down-regulated miRNAs were has-miR-1231, has-miR-195, has-miR-143, and has-miR-145 (median false discovery rate<5%).
CONCLUSIONS: Significant differential expression of miRNA was found between the UC mouse and UCRCC mouse, which may be related to the onset, erosion and transfer of colorectal cancer.
Copyright © 2013 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carcinogenesis; Colorectal cancer; MicroRNA; Microarray; Mouse model; Ulcerative colitis

Mesh:

Substances:

Year:  2013        PMID: 24144030     DOI: 10.1016/S1995-7645(13)60174-1

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  23 in total

Review 1.  Role of MiRNAs in Inflammatory Bowel Disease.

Authors:  Bo Cao; Xin Zhou; Jiaojiao Ma; Wei Zhou; Wanli Yang; Daiming Fan; Liu Hong
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199

2.  A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.

Authors:  Yuji Toiyama; Yoshinaga Okugawa; Koji Tanaka; Toshimitsu Araki; Keiichi Uchida; Asahi Hishida; Motoi Uchino; Hiroki Ikeuchi; Seiichi Hirota; Masato Kusunoki; C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2017-08-25       Impact factor: 22.682

3.  MiR-29a promotes intestinal epithelial apoptosis in ulcerative colitis by down-regulating Mcl-1.

Authors:  Bo Lv; Zhihui Liu; Shuping Wang; Fengbin Liu; Xiaojun Yang; Jiangtao Hou; Zhengkun Hou; Bin Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

4.  MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.

Authors:  Bo Wang; Zhan-long Shen; Zhi-dong Gao; Gang Zhao; Chun-you Wang; Yang Yang; Ji-zhun Zhang; Yi-chao Yan; Chao Shen; Ke-wei Jiang; Ying-jiang Ye; Shan Wang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  WGCNA Reveals Key Roles of IL8 and MMP-9 in Progression of Involvement Area in Colon of Patients with Ulcerative Colitis.

Authors:  Xue Lin; Jin Li; Qiu Zhao; Jue-Rong Feng; Qian Gao; Jia-Yan Nie
Journal:  Curr Med Sci       Date:  2018-04-30

6.  Cisplatin-mediated down-regulation of miR-145 contributes to up-regulation of PD-L1 via the c-Myc transcription factor in cisplatin-resistant ovarian carcinoma cells.

Authors:  Q Sheng; Y Zhang; Z Wang; J Ding; Y Song; W Zhao
Journal:  Clin Exp Immunol       Date:  2019-12-27       Impact factor: 4.330

7.  Down-regulation of miR-215 attenuates lipopolysaccharide-induced inflammatory injury in CCD-18co cells by targeting GDF11 through the TLR4/NF-kB and JNK/p38 signaling pathways.

Authors:  Boyang Sun; Kai Xing; Chen Qi; Ke Yan; Yan Xu
Journal:  Histol Histopathol       Date:  2020-11-04       Impact factor: 2.303

8.  MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.

Authors:  Min Wang; Junjie Zhang; Linlong Tong; Xiaofei Ma; Xinguang Qiu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  Identification of potential biomarkers and pathways in ulcerative colitis with combined public mRNA and miRNA expression microarray data analysis.

Authors:  Lili Yang; Yaoyao Bian; Zhengjun Li; Yan Yan; Junyi Li; Wenlin Li; Li Zeng
Journal:  J Gastrointest Oncol       Date:  2019-10

Review 10.  MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways.

Authors:  Shi-Yun Cui; Rui Wang; Long-Bang Chen
Journal:  J Cell Mol Med       Date:  2014-08-15       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.